{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:55:46Z","timestamp":1791388546256,"version":"4.3.3"},"reference-count":109,"publisher":"Elsevier","isbn-type":[{"value":"9780443431906","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.pmbts.2026.01.028","type":"book-chapter","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:15:34Z","timestamp":1770466534000},"page":"305-337","source":"Crossref","is-referenced-by-count":0,"title":["Recent advances of microbial medicine to prevent and treat cardiovascular disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3322-820X","authenticated-orcid":false,"given":"Shriram","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anagha","family":"NK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0008-0480","authenticated-orcid":false,"given":"Sanjay K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1085041","article-title":"The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases","volume":"14","author":"Zhen","year":"2023","journal-title":"Front Endocrinol"},{"issue":"13","key":"10.1016\/bs.pmbts.2026.01.028_bib4","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/bs.pmbts.2026.01.028_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4330\/wjc.v12.i4.110","article-title":"Role of gut microbiota in cardiovascular diseases","volume":"12","author":"Novakovic","year":"2020","journal-title":"World J Cardiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-021-00499-1","article-title":"The promise of the gut microbiome as part of individualized treatment strategies","volume":"19","author":"Schupack","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2023.100096","article-title":"Implications of the gut microbiome in cardiovascular diseases: association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine","volume":"19","author":"Singh","year":"2024","journal-title":"Med Microecol"},{"issue":"16","key":"10.1016\/bs.pmbts.2026.01.028_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","article-title":"Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review","volume":"73","author":"Tang","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib11","first-page":"H923","article-title":"The gut microbiome and cardiovascular disease: current knowledge and clinical potential","volume":"317","author":"Ahmad","year":"2019","journal-title":"Am J"},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.028_bib12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"17","key":"10.1016\/bs.pmbts.2026.01.028_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib14","article-title":"Link between microbiota and hypertension: focus on LPS\/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics","volume":"137","author":"Grylls","year":"2021","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"7","key":"10.1016\/bs.pmbts.2026.01.028_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory mechanisms contributing to endothelial dysfunction","volume":"9","author":"Theofilis","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"issue":"6380","key":"10.1016\/bs.pmbts.2026.01.028_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.pmbts.2026.01.028_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.028_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physiolgenomics.00136.2014","article-title":"Evidence for a link between gut microbiota and hypertension in the Dahl rat","volume":"47","author":"Mell","year":"2015","journal-title":"Physiol Genomics"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","article-title":"Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts","volume":"71","author":"Kummen","year":"2018","journal-title":"JACC"},{"issue":"8","key":"10.1016\/bs.pmbts.2026.01.028_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0007114511004703","article-title":"Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults","volume":"107","author":"Jones","year":"2012","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib23","first-page":"897","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertens Dallas Tex 1979"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104177","article-title":"Effects of probiotic supplementation on cardiovascular risk factors in hypercholesterolemia: a systematic review and meta-analysis of randomized clinical trial","volume":"74","author":"Jiang","year":"2020","journal-title":"J Funct Foods"},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.028_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0007114511004703","article-title":"Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults","volume":"107","author":"Jones","year":"2012","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.028_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2012.126","article-title":"Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial","volume":"66","author":"Jones","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009679","article-title":"The effects of probiotics on total cholesterol","volume":"97","author":"Wang","year":"2018","journal-title":"Med (Baltim)"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib29","first-page":"897","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertens Dallas Tex 1979"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139795","article-title":"Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals","volume":"10","author":"Shimizu","year":"2015","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/bs.pmbts.2026.01.028_bib32","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.12998\/wjcc.v11.i19.4612","article-title":"Fecal microbiota transplantation in patients with metabolic syndrome and obesity: a randomized controlled trial","volume":"11","author":"da Ponte Neto","year":"2023","journal-title":"World J Clin Cases"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijfoodmicro.2006.08.015","article-title":"Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects","volume":"113","author":"Nguyen","year":"2007","journal-title":"Int J Food Microbiol"},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.028_bib34","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2012.126","article-title":"Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial","volume":"66","author":"Jones","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.028_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clnu.2013.05.015","article-title":"Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial","volume":"33","author":"Asemi","year":"2014","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/nu16040546","article-title":"The anti-inflammatory and curative exponent of probiotics: a comprehensive and authentic ingredient for the sustained functioning of major human organs","volume":"16","author":"Virk","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115276","article-title":"The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials","volume":"165","author":"Duan","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13098-022-00858-1","article-title":"The effect of synbiotic supplementation on atherogenic indices, hs-CRP, and malondialdehyde, as major CVD-related parameters, in women with gestational diabetes mellitus: a secondary data-analysis of a randomized double-blind, placebo-controlled study","volume":"14","author":"Nabhani","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/gmic.1.3.12127","article-title":"Safety assessment of probiotics for human use","volume":"1","author":"Sanders","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1272754","article-title":"Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics","volume":"14","author":"Spacova","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib42","doi-asserted-by":"crossref","unstructured":"Postbiotics: an evolving term within the functional foods field | Request PDF. ResearchGate. https:\/\/doi.org\/10.1016\/j.tifs.2018.03.009.","DOI":"10.1016\/j.tifs.2018.03.009"},{"issue":"9","key":"10.1016\/bs.pmbts.2026.01.028_bib43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The international scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.028_bib44","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/bs.pmbts.2026.01.028_bib45","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal CCS"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib47","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/HYPERTENSIONAHA.122.18558","article-title":"Short-chain fatty acid receptors and blood pressure regulation: council on hypertension mid-career award for research excellence 2021","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/bs.pmbts.2026.01.028_bib48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00726-022-03161-5","article-title":"Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease","volume":"54","author":"Paeslack","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib49","article-title":"The mechanism underlying the influence of indole-3-propionic acid: a relevance to metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib50","first-page":"263","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv Pharmacol San Diego Calif"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116735","article-title":"GPR41 and GPR43: from development to metabolic regulation","volume":"175","author":"Lee","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903526","article-title":"Dual role of indoles derived from intestinal microbiota on human health","volume":"13","author":"Ye","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2024.110769","article-title":"Emerging biopolymer nanocarriers for controlled and protective delivery of food bioactive compounds- current status and future perspective","volume":"160","author":"Venkidasamy","year":"2025","journal-title":"Food Hydrocoll"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.693412","article-title":"Therapeutic and improving function of lactobacilli in the prevention and treatment of cardiovascular-related diseases: a novel perspective from gut microbiota","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.028_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.afres.2024.100468","article-title":"Fermentation\u2019s pivotal role in shaping the future of plant-based foods: an integrative review of fermentation processes and their impact on sensory and health benefits","volume":"4","author":"Abbaspour","year":"2024","journal-title":"Appl Food Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.028_bib57","first-page":"754","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.028_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/oby.22700","article-title":"Genetically engineered Escherichia coli Nissle 1917 Secreting GLP-1 analog exhibits potential antiobesity effect in high-fat diet-induced obesity mice","volume":"28","author":"Ma","year":"2020","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/cjid\/6675676","article-title":"Administration of a next-generation probiotic Escherichia coli Nissle 1917-GLP-1 alleviates diabetes in mice with type 1 and type 2 diabetes","volume":"2025","author":"Luo","year":"2025","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1505218","article-title":"Bacteroides thetaiotaomicron enhances oxidative stress tolerance through rhamnose-dependent mechanisms","volume":"15","author":"Xie","year":"2024","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib61","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1161\/ATVBAHA.123.318126","article-title":"Bioengineering cell therapy for treatment of peripheral artery disease","volume":"44","author":"Huang","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib62","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","article-title":"Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements","volume":"15","author":"Hayashi","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108640","article-title":"Engineering encapsulated living bacteria for advanced healthcare management","volume":"83","author":"Teng","year":"2025","journal-title":"Biotechnol Adv"},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.028_bib64","first-page":"754","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol Clin Pract J Am Gastroenterol Assoc"},{"issue":"8","key":"10.1016\/bs.pmbts.2026.01.028_bib65","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s42255-021-00430-7","article-title":"Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1\/2a study","volume":"3","author":"Puurunen","year":"2021","journal-title":"Nat Metab"},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.028_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/oby.22700","article-title":"Genetically engineered Escherichia coli Nissle 1917 Secreting GLP-1 analog exhibits potential antiobesity effect in high-fat diet-induced obesity mice","volume":"28","author":"Ma","year":"2020","journal-title":"Obes Silver Spring Md"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymben.2021.10.005","article-title":"Engineering bacteroides thetaiotaomicron to produce non-native butyrate based on a genome-scale metabolic model-guided design","volume":"68","author":"Kim","year":"2021","journal-title":"Metab Eng"},{"issue":"9","key":"10.1016\/bs.pmbts.2026.01.028_bib68","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe-targeted non-lethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib69","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/nar\/gku1378","article-title":"Multilayered genetic safeguards limit growth of microorganisms to defined environments","volume":"43","author":"Gallagher","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"Pt 7","key":"10.1016\/bs.pmbts.2026.01.028_bib70","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1099\/mic.0.066308-0","article-title":"Building-in biosafety for synthetic biology","volume":"159","author":"Wright","year":"2013","journal-title":"Microbiol Read Engl"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jsfa.9227","article-title":"Legislation governing genetically modified and genome\u2010edited crops in Europe: the need for change","volume":"99","author":"Halford","year":"2019","journal-title":"J Sci Food Agric"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0017-2017","article-title":"U.S. regulatory considerations for development of live biotherapeutic products as drugs","volume":"5","author":"Dreher-Lesnick","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib73","unstructured":"Commissioner O\u00a0of the\u00a0Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information. July 2, 2021. Accessed December 10, 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/early-clinical-trials-live-biotherapeutic-products-chemistry-manufacturing-and-control-information."},{"key":"10.1016\/bs.pmbts.2026.01.028_bib74","unstructured":"Quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells - Scientific guideline | European Medicines Agency (EMA). May 3, 2012. Accessed December 10, 2025. https:\/\/www.ema.europa.eu\/en\/quality-non-clinical-clinical-aspects-medicinal-products-containing-genetically-modified-cells-scientific-guideline."},{"issue":"9","key":"10.1016\/bs.pmbts.2026.01.028_bib75","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fmed.2020.00237","article-title":"Live biotherapeutic products, a road map for safety assessment","volume":"7","author":"Rouanet","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12934-022-01799-0","article-title":"Engineered probiotics","volume":"21","author":"Ma","year":"2022","journal-title":"Microb Cell Factories"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib78","unstructured":"Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic\u2019s Synthetic BioticTM Medicine in Development as a Potential Treatment for Hyperammonemia - Synlogic. Accessed December 10, 2025. https:\/\/investor.synlogictx.com\/news-releases\/news-release-details\/science-translational-medicine-publishes-first-human-clinical."},{"key":"10.1016\/bs.pmbts.2026.01.028_bib79","unstructured":"sybx-10k_20191231.htm. Accessed December 10, 2025. https:\/\/www.sec.gov\/Archives\/edgar\/data\/1527599\/000156459020010261\/sybx-10k_20191231.htm?utm_source=chatgpt.com."},{"issue":"13","key":"10.1016\/bs.pmbts.2026.01.028_bib80","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an Engineered E. coli nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib81","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2350785","article-title":"Diet-microbiota associations in gastrointestinal research: a systematic review","volume":"16","author":"Duncanson","year":"2024","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/bs.pmbts.2026.01.028_bib82","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/bs.pmbts.2026.01.028_bib83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003863","article-title":"Plant-based diets and incident cardiovascular disease and all-cause mortality in African Americans: a cohort study","volume":"19","author":"Weston","year":"2022","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib85","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"issue":"7341","key":"10.1016\/bs.pmbts.2026.01.028_bib86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"7682","key":"10.1016\/bs.pmbts.2026.01.028_bib87","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"issue":"7405","key":"10.1016\/bs.pmbts.2026.01.028_bib88","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib89","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1038\/s41467-018-05249-7","article-title":"Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice","volume":"9","author":"Natividad","year":"2018","journal-title":"Nat Commun"},{"issue":"7541","key":"10.1016\/bs.pmbts.2026.01.028_bib90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"issue":"7521","key":"10.1016\/bs.pmbts.2026.01.028_bib91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature13793","article-title":"Artificial sweeteners induce glucose intolerance by altering the gut microbiota","volume":"514","author":"Suez","year":"2014","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib92","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fmicb.2017.01809","article-title":"Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice","volume":"8","author":"Constante","year":"2017","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2026.01.028_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/md19020054","article-title":"Microbiota, a new playground for the omega-3 polyunsaturated fatty acids in cardiovascular diseases","volume":"19","author":"Rousseau","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1522373","article-title":"Polyphenol-mediated microbiome modulation in STEMI patients: a pilot study","volume":"12","author":"Issilbayeva","year":"2025","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib95","first-page":"539","article-title":"Probiotic yogurt improves antioxidant status in type 2 diabetic patients","volume":"28","author":"Ejtahed","year":"2012","journal-title":"Nutr Burbank Los Angel Cty Calif"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib96","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.copbio.2016.11.010","article-title":"Health benefits of fermented foods: microbiota and beyond","volume":"44","author":"Marco","year":"2017","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib97","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tifs.2023.06.013","article-title":"Targeting gut microbiota and metabolism as the major probiotic mechanism - an evidence-based review","volume":"138","author":"Ma","year":"2023","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/bs.pmbts.2026.01.028_bib98","article-title":"The use of faecal microbiota transplantation (FMT) in Europe: a Europe-wide survey","volume":"9","author":"Baunwall","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib99","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/bs.pmbts.2026.01.028_bib100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","article-title":"Therapeutic potential of fecal microbiota transplantation","volume":"145","author":"Smits","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib101","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/bs.pmbts.2026.01.028_bib102","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.12998\/wjcc.v11.i19.4612","article-title":"Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial","volume":"11","author":"da Ponte Neto","year":"2023","journal-title":"World J Clin Cases"},{"issue":"4","key":"10.1016\/bs.pmbts.2026.01.028_bib103","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/bs.pmbts.2026.01.028_bib104","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/nu12030605","article-title":"The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases","volume":"12","author":"Sanchez-Rodriguez","year":"2020","journal-title":"Nutrients"},{"issue":"7341","key":"10.1016\/bs.pmbts.2026.01.028_bib105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pmbts.2026.01.028_bib106","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.123.322055","article-title":"Gut microbiota and microbial metabolism in early risk of cardiometabolic disease","volume":"132","author":"Gabriel","year":"2023","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/bs.pmbts.2026.01.028_bib107","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","article-title":"Microbiome at the frontier of personalized medicine","volume":"92","author":"Kashyap","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/bs.pmbts.2026.01.028_bib108","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","article-title":"Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2026.01.028_bib109","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41467-024-46888-3","article-title":"Multi-omic integration of microbiome data for identifying disease-associated modules","volume":"15","author":"Muller","year":"2024","journal-title":"Nat Commun"}],"container-title":["Progress in Molecular Biology and Translational Science","Live Biotherapeutics: Advancing Microbial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117326000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117326000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:31:51Z","timestamp":1791387111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117326000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431906"],"references-count":109,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2026.01.028","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}